Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trial

  • 📰 CNN
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 22%
  • Publisher: 95%

JUST IN: Novavax says its coronavirus vaccine has an overall efficacy of 90.4% and was 'generally well-tolerated' in a Phase 3 trial in the US and Mexico

United States Headlines News

United States Latest News, United States Headlines

The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the United States and Mexico.

Additional analyses of the trial are ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. Novavax to seek US authorization of its Covid-19 vaccine in third quarter, CEO saysThe trial results appear consistent with the efficacy and safety profile the vaccine previously showed in a Phase 3 trial conducted in the United Kingdom, Dr. Gregory Glenn, president of research and development for Novavax, told CNN.

Novavax's coronavirus vaccine, called NVX-CoV2373, differs from the three vaccines already in use in the United States. The vaccine relies on what is called recombinant nanoparticle technology and Novavax's adjuvant, called Matrix-M, to stimulate an immune response.The two mRNA vaccines that were authorized last year in the United States -- from Pfizer/BioNTech and Moderna -- both use genetic material to stimulate an immune response.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I invested $100 in bitcoin online trade with help from blincredits and made $1000 within a few hours duration trading from home. so excited and think it's nice sharing the news.

Please help me! My name is Lin donglong, an employee of China telecom fuzhou branch. Company manager huang fei (communist party of China) organized the leadership of the gang of evil forces brutal persecution: surveillance location, insult,abuse, framed to take nude photos of me

Happy birthday Mr. President realDonaldTrump POTUS45 Best President ever! 2024 The real GOAT!!

❤️

Novavax researchers also took a close look at sequencing data for 54 of the 77 Covid - 19 cases in the study .

There were 77 Covid -19 cases that emerged among participants during the study , according to Novavax .Sixty three cases were in the people in the placebo group and 14 in the vaccine group .

Good. Another vaccine to help get the world back to normal sooner

The company said the vaccine was ' generally well- tolerated ' and common side effects included pain at the injection site , lasting less than three days , and fatigue ,, headache and muscle pain , lasting less than two days .

good

Some of the participants were given a placebo and some were administered two doses of the Novavax vaccine 21 days apart .

The study launched in December and enrolled 29,960 adults across 113 sites in the United States and six sites in Mexico .

I’ll wait for the peer review.

Phase 3 phase 2 is still experimental,only this time we de people are the gunie pigs lab rats...yep!they invent the bio germ in a lab&tested it full scale on us unsuspecting ones,their objective cripple 🌎's economic system=CCP's XPING EMPOROR OF 🌎 China's way or de highway...

Great news

Additional analysis of the trial are ongoing ,, according to the company ,and will be submitted to peer reviewed journals for publication.

Generally well tolerated... Well that could have been worded better

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax COVID-19 vaccine more than 90% effective in U.S. trialNovavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.
Source: Reuters - 🏆 2. / 97 Read more »

Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic diseaseJUST IN: American biotechnology company Novavax announces that its experimental COVID-19 vaccine is more than 90% effective against symptomatic disease in late-stage clinical trials.
Source: ABC - 🏆 471. / 51 Read more »

Novavax: Large study finds COVID-19 shot about 90% effectiveVaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico. The vaccine was about 90% effective overall and preliminary data showed it was safe, the company said. nauman_3 wait for this Lololol Is this a Novavax Jokavich? Get it?!
Source: AP - 🏆 728. / 51 Read more »

John Gabriel, Actor on ‘Ryan’s Hope,’ Dies at 90John Gabriel, the actor and singer who portrayed the controlling Dr. Seneca Beaulac for the first 10 years of the ABC soap opera Ryan’s Hope, has died. He was 90. Gabriel’s death was an… I TRULY LOVED him on Ryan’s Hope! May John Gabriel be Resting In Eternal Peace. 💔😭🙏🏼 And that God Blesses his Family and Friends. ❤️🙏🏼❤️ Awwww. I remember this.
Source: THR - 🏆 411. / 53 Read more »

John Gabriel Dies: ‘Ryan’s Hope’ Star, ‘Charles Grodin’ Talk Show Producer Was 90John Gabriel, the actor known for his turn in ABC soap opera Ryan’s Hope, has died. The Daytime Emmy nominee was 90 years old. While no details were immediately available regarding a cause of… Sad news to hear. Soap opera legend! May he rest in peace rip
Source: DEADLINE - 🏆 109. / 63 Read more »

Novavax COVID-19 vaccine more than 90% effective in U.S. trialNovavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.
Source: Reuters - 🏆 2. / 97 Read more »